Jessica Gibson
ARIEL Precision Medicine
Chief Executive Officer
Ms. Jessica Gibson is the chief executive officer and co-founder of Ariel Precision Medicine, which is positioned as the solution for early, targeted management of complex chronic disorders, starting with pancreatic diseases. She has led the development, clinical validation and commercial launch of Ariel’s first product, PancreasDx®, and a cloud-based digital health platform designed to simplify the management of complex patients with Ariel’s proprietary expert system. Ms. Gibson has focused on working with multiple stakeholders, including establishing partnerships with the National Pancreas Foundation, patient advocacy groups and pharmaceutical companies. Ms. Gibson served as chief commercial officer of Ariel Precision Medicine until 2016, leveraging her broad healthcare and pharma experience working in sales, training and medical marketing with Purdue and Shionogi Pharmaceuticals Inc. Ms. Gibson accomplished significant growth with her work in the biotechnology field with Gene Wiz Inc. until 2007, when she was recruited into the pharmaceutical industry. Before entering the industry, she worked in emergency care and in academia at the University of Pittsburgh, developing a great appreciation for the practice of medicine and research working with the Center for Emergency Medicine and Cancer Institute.
Ms. Gibson received her executive M.B.A. from Liberty University after earning a B.S. in emergency medicine from the University of Pittsburgh. Ms. Gibson lives in Southern California with her husband and two boys.